These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 26561981)
1. One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy. Halazun KJ; Mathur AK; Rana AA; Massie AB; Mohan S; Patzer RE; Wedd JP; Samstein B; Subramanian RM; Campos BD; Knechtle SJ Am J Transplant; 2016 Jan; 16(1):137-42. PubMed ID: 26561981 [TBL] [Abstract][Full Text] [Related]
2. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Volk ML; Lok AS; Pelletier SJ; Ubel PA; Hayward RA Gastroenterology; 2008 Nov; 135(5):1568-74. PubMed ID: 19009713 [TBL] [Abstract][Full Text] [Related]
3. The effects of Share 35 on the cost of liver transplantation. Berumen J; Misel M; Vodkin I; Halldorson JB; Mekeel KL; Hemming A Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235131 [TBL] [Abstract][Full Text] [Related]
5. Improved posttransplant mortality after share 35 for liver transplantation. Kwong AJ; Goel A; Mannalithara A; Kim WR Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179 [TBL] [Abstract][Full Text] [Related]
6. Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35. Chow EK; Massie AB; Luo X; Wickliffe CE; Gentry SE; Cameron AM; Segev DL Am J Transplant; 2017 Feb; 17(2):512-518. PubMed ID: 27457221 [TBL] [Abstract][Full Text] [Related]
7. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35. Nekrasov V; Matsuoka L; Rauf M; Kaur N; Cao S; Groshen S; Alexopoulos SP Am J Transplant; 2016 Oct; 16(10):2912-2924. PubMed ID: 27063579 [TBL] [Abstract][Full Text] [Related]
8. The Impact of Share 35 Policy on Patient Survival in Patients Undergoing Liver Transplantation With Gender- and Race-Mismatched Donors: An Analysis of the United Network for Organ Sharing Registry. Zhang Y; Boktour MR Prog Transplant; 2018 Jun; 28(2):151-156. PubMed ID: 29558873 [TBL] [Abstract][Full Text] [Related]
9. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score. Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152 [TBL] [Abstract][Full Text] [Related]
10. The impact of broader regional sharing of livers: 2-year results of "Share 35". Edwards EB; Harper AM; Hirose R; Mulligan DC Liver Transpl; 2016 Apr; 22(4):399-409. PubMed ID: 26890858 [TBL] [Abstract][Full Text] [Related]
11. Overview of the MELD score and the UNOS adult liver allocation system. Martin AP; Bartels M; Hauss J; Fangmann J Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345 [TBL] [Abstract][Full Text] [Related]
12. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA. Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564 [TBL] [Abstract][Full Text] [Related]
13. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. Trotter JF; Osgood MJ JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206 [TBL] [Abstract][Full Text] [Related]
14. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers. Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057 [TBL] [Abstract][Full Text] [Related]
15. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy. Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638 [TBL] [Abstract][Full Text] [Related]
16. Financial Impact of Liver Sharing and Organ Procurement Organizations' Experience With Share 35: Implications for National Broader Sharing. Fernandez H; Weber J; Barnes K; Wright L; Levy M Am J Transplant; 2016 Jan; 16(1):287-91. PubMed ID: 26372681 [TBL] [Abstract][Full Text] [Related]
17. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States. Yoo HY; Thuluvath PJ Liver Int; 2005 Jun; 25(3):536-41. PubMed ID: 15910490 [TBL] [Abstract][Full Text] [Related]
18. Re-weighting the model for end-stage liver disease score components. Sharma P; Schaubel DE; Sima CS; Merion RM; Lok AS Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388 [TBL] [Abstract][Full Text] [Related]
19. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004). Shneider BL; Suchy FJ; Emre S Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460 [TBL] [Abstract][Full Text] [Related]
20. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center. Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]